Improving PET imaging for better cancer diagnosis and monitoring
Optimization of Clinical and Research PET Imaging
This study is looking to make cancer imaging better by finding ways to use less radioactive material and reduce scan time while still getting clear results, so it can help doctors spot tumors and track how well treatments are working for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10580601 on NIH RePORTER |
What this research studies
This research focuses on enhancing the performance of the latest PET/CT imaging systems to improve cancer diagnosis and treatment monitoring. By using advanced image quality measures and correlating them with simpler metrics, the study aims to optimize the amount of radioactive material injected and the time spent on imaging without compromising the quality of results. The research will involve realistic patient studies to evaluate how different scanner designs and patient characteristics affect imaging outcomes, particularly in detecting tumors and assessing treatment responses.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients undergoing PET scans for cancer diagnosis or treatment evaluation.
Not a fit: Patients who are not undergoing PET imaging or those with conditions not related to cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more efficient and effective PET imaging protocols, improving cancer diagnosis and treatment monitoring for patients.
How similar studies have performed: Previous research has shown promising results in optimizing imaging protocols, suggesting that this approach could lead to significant advancements in PET imaging.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Surti, Suleman — University of Pennsylvania
- Study coordinator: Surti, Suleman
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.